Clinical Trial Update: A Study of Roginolisib in Combination With Ruxolitinib in Patients With Myelofibrosis (MF) Who Are Unresponsive to JAK Inhibitors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on Roginolisib in combination with Ruxolitinib for myelofibrosis patients unresponsive to JAK inhibitors. The study is a Phase 1/2 trial c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Roginolisib (roginolisib)
• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: iOnctura | Conditions: Myelofibrosis (MF) | Phase 1, Phase 2 | Status: RECRUITING